A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie has announced a new clinical study titled ‘A ...

Parkinson’s disease affects over 10 million people globally, with incidence increasing after age 60. Dopamine-producing neuron loss leads to both motor and non-motor symptoms, including tremors, sleep ...

Parkinson’s disease (PD) is a growing global health challenge, affecting millions worldwide and imposing significant burdens ...

Scientists have finally pinned down a protein that’s largely responsible for Parkinson’s disease. Known as PINK1, the protein has been linked to the disease for decades but its structure and how to ...

Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug repurposing clinical trial initiative ...

The treatment uses a modified, harmless virus to deliver healthy genes to a patient’s cells to treat genetic diseases. Read more at straitstimes.com. Read more at straitstimes.com.

Throughout 2021 and 2022, researchers at Ghent University Hospital in Belgium watched with cautious optimism as nearly 50 people with early stage Parkinson’s disease visited the clinic as part of a ...

More than a decade after retiring from football, Brett Favre says he has Parkinson’s disease. Favre told a congressional hearing Tuesday that he had been recently diagnosed. There are nearly 90,000 ...

Oral bacteria that migrate to the gut can generate metabolites that reach the brain and accelerate Parkinson’s disease.

Recent scientific discoveries are challenging traditional views of Parkinson’s disease, suggesting that this neurological condition might actually begin in an unexpected place, the digestive system.